Technical Principles and Experimental Application Guide of Exosome Quantitative Detection Kit

As crucial mediators of intercellular communication, exosomes have gained increasing research value in tumor progression, immune regulation, neurodegenerative diseases and other fields. However, the accurate and rapid quantitative detection of exosome concentrations in body fluids or culture supernatants remains a technical bottleneck restricting scientific progress. The exosome quantitative detection kit based on the sandwich ELISA method provides researchers with a stable and reliable exosome quantification solution through a dual-antibody recognition strategy.

What is an Exosome Quantitative Detection Kit?

The exosome quantitative detection kit is an immunological tool that employs the dual-antibody sandwich ELISA technique to specifically recognize and quantify exosome concentrations in samples. The kit uses anti-CD9 antibody as the capture antibody coated on microplates and anti-CD81 antibody as the detection antibody, enabling precise measurement of intact exosomes by identifying those that co-express CD9 and CD81 surface markers. Recombinant fusion proteins are used as standards, avoiding the defects of instability and large batch-to-batch variation of natural exosomes, ensuring the repeatability and comparability of detection results.

What is the Working Principle?

The core of this technology lies in the "dual-marker co-recognition" strategy. Exosome membranes are rich in members of the tetraspanin family, among which CD9, CD63, and CD81 are classic exosome markers. The kit captures exosomes in samples via immobilized anti-CD9 antibodies, followed by the addition of enzyme-labeled anti-CD81 detection antibodies. A "capture antibody-exosome-detection antibody" sandwich complex can only form when exosomes co-express CD9 and CD81. This dual verification mechanism effectively eliminates interference from free proteins or non-vesicular structures, ensuring detection specificity.

After the color reaction is completed, the absorbance at 450 nm is read using a microplate reader, and the exosome concentration in the sample is calculated based on the standard curve. The entire process does not require complex equipment and can be completed with a standard microplate reader.

Which Experiments Require Exosome Quantification?

• Tumor Microenvironment Research: Detect the content of exosomes secreted by tumor cells and evaluate changes in exosome release by tumor cells under different treatment conditions (e.g., hypoxia, drug stimulation).
• Liquid Biopsy Development: Quantitatively analyze exosome concentrations in clinical samples such as serum, plasma, and urine to explore their potential as disease diagnostic or prognostic markers.
• Drug Mechanism of Action Research: Evaluate the inhibitory effect of candidate drugs on cellular exosome secretion, providing evaluation indicators for the screening of anti-tumor or immunomodulatory drugs.
• Intercellular Communication Research: Quantitatively compare exosome secretion levels of different cell types or differentiation states to reveal differences in intercellular communication intensity.
• Exosome Preparations Quality Control: Rapidly assess the concentration and integrity of preparations after exosome extraction and purification, serving as a quality control tool for purification process optimization.
• Neurodegenerative Disease Research: Detect the content of neurogenic exosomes in cerebrospinal fluid or blood to explore their correlation with disease progression.

What Details Should Be Noted in the Operating Procedure?

• Pre-Experiment Preparation: All reagents need to equilibrate at room temperature for at least 15 minutes to avoid temperature differences affecting antigen-antibody binding efficiency. The concentrated wash buffer must be precisely diluted 20-fold with distilled or deionized water, as water purity directly affects background signals.
• Standard Curve Setup: A complete set of standard gradients (usually including 0, 7.8, 15.6, 31.25, 45 ng/mL concentration points) must be set for each experiment, using XY linear fitting with a required correlation coefficient R²≥0.99. Standards should be processed synchronously with test samples to eliminate batch effects.
• Sample Loading Specifications: Add 100μL of standards or samples per well; a multi-channel pipette is recommended to improve loading consistency. Seal the plate immediately with a sealing membrane after loading and incubate at 37℃ in the dark for 60 minutes to prevent concentration deviation caused by liquid evaporation.
• Washing Key Step: Wash 3 times with working wash buffer after incubation, 200-250μL per well each time. Insufficient washing leads to increased non-specific adsorption and elevated background signals. Blot gently on absorbent paper after washing to avoid residual liquid diluting subsequent reagents.
• Color Reaction: Mix chromogenic solutions A and B in equal volumes and use within 2 minutes of preparation. Add 100μL of chromogenic substrate per well and react at 37℃ in the dark for 30 minutes. Strictly control the color development time to avoid signal oversaturation.
• Termination and Reading: Complete OD450 measurement within 3 minutes after adding 50μL of stop solution. Delayed reading may cause signal attenuation and affect quantitative accuracy.

How to Ensure the Reliability of Detection Results?

• Consistency of Sample Processing: Serum or plasma samples are recommended to use a unified differential centrifugation pretreatment method to remove cells and cell debris. Cell culture supernatants should be collected under serum-free or low-serum culture conditions to avoid interference from bovine serum exosomes.
• Stability of Standard Curve: Although the kit uses recombinant protein standards, batch-to-batch variations may exist. It is recommended to re-draw the standard curve for each experiment, and standards from different kit batches should not be mixed.
• Exosome Integrity Assessment: The kit indirectly reflects exosome integrity by detecting vesicular structures co-expressing CD9 and CD81. If the detection results differ significantly from nanoparticle tracking analysis (NTA) results, it may indicate the presence of a large number of damaged or marker-deficient vesicular structures in the sample.
• Negative Control Setup: It is recommended to set up isotype controls for detection antibodies or blank controls without exosomes to evaluate non-specific binding levels. Some sample matrices (e.g., high-lipid serum) may interfere with detection, and matrix effects need to be excluded by dilution methods.
• Detection Range Validation: The concentration of test samples should fall within the linear range of the standard curve. High-concentration samples require gradient dilution with diluent, while low-concentration samples need enrichment treatment.

Result Interpretation and Limitation Analysis

A typical standard curve shows a good linear relationship, and the R² value reflects the standardization of experimental operations. The exosome concentration of test samples is calculated by substituting the absorbance value into the standard curve equation. It should be clarified that the kit detects the concentration of vesicles expressing CD9 and CD81, not the absolute number of exosomes. The expression profiles of surface markers on exosomes from different cell sources vary, and some exosomes may have low expression of CD9 or CD81, resulting in detected values lower than the actual concentration.

In addition, the kit cannot distinguish exosomes from certain microvesicle structures, which differ in particle size and biogenesis mechanism but share overlapping surface markers. Therefore, in studies requiring precise differentiation of exosome subpopulations, multi-dimensional verification combining western blotting, electron microscopy, or high-throughput sequencing is recommended.

Conclusion

The exosome quantitative detection kit provides researchers with a practical tool for rapid assessment of exosome content through a simplified ELISA process. Despite certain limitations in marker specificity and structural discrimination ability, its convenience in high-throughput screening, process quality control, and preclinical research is irreplaceable. As exosome research advances from exploratory stages to clinical translation, establishing standardized quantitative detection processes will become a fundamental support for promoting the development of this field.

Recommended Absin Exosome Quantitative Detection Kits:

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio